Biopol Chemicals (NSE:BIOPOL) Scaled Net Operating Assets: 1.84 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:BIOPOL Biopol Chemicals Ltd NSE:BIOPOL
20 GF Score
Price ₹97.80
! 4 Warning Signs
View Full Analysis

What is Biopol Chemicals Scaled Net Operating Assets?

Biopol Chemicals NSE:BIOPOL +0.31% 20 Scaled Net Operating Assets is 1.84 as of Mar. 2026. GuruFocus rates NSE:BIOPOL with a GF Score™ of 20/100. The stock has 4 warning signs investors should review.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Biopol Chemicals's operating assets for the quarter that ended in Mar. 2026 was ₹692.6 Mil. Biopol Chemicals's operating liabilities for the quarter that ended in Mar. 2026 was ₹113.9 Mil. Biopol Chemicals's Total Assets for the quarter that ended in Mar. 2025 was ₹314.8 Mil. Therefore, Biopol Chemicals's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2026 was 1.84.


Biopol Chemicals Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for Biopol Chemicals's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biopol Chemicals Scaled Net Operating Assets Chart

Biopol Chemicals Annual Data
Trend Mar24 Mar25 Mar26
Scaled Net Operating Assets
0.72 1.14 1.84

Biopol Chemicals Semi-Annual Data
Mar24 Mar25 Mar26
Scaled Net Operating Assets 0.72 1.14 1.84

NSE:BIOPOL vs LIN, SHW, ECL: Scaled Net Operating Assets Comparison

For the Specialty Chemicals subindustry, Biopol Chemicals's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biopol Chemicals Scaled Net Operating Assets vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Biopol Chemicals's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Biopol Chemicals's Scaled Net Operating Assets falls into.


NSE:BIOPOL
20GF Score
Biopol Chemicals Ltd NSE:BIOPOL
Scaled Net Operating Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biopol Chemicals Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Biopol Chemicals's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Mar. 2026 is calculated as

Scaled Net Operating Assets (SNOA)(A: Mar. 2026 )
=(Operating Assets (A: Mar. 2026 )-Operating Liabilities (A: Mar. 2026 ))/Total Assets (A: Mar. 2025 )
=(692.569-113.895)/314.753
=1.84

where

Operating Assets(A: Mar. 2026 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=697.753 - 5.184
=692.569

Operating Liabilities(A: Mar. 2026 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=198.544 - 50.555 - 34.094
=113.895

Biopol Chemicals's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2026 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Mar. 2026 )
=(Operating Assets (Q: Mar. 2026 )-Operating Liabilities (Q: Mar. 2026 ))/Total Assets (Q: Mar. 2025 )
=(692.569-113.895)/314.753
=1.84

where

Operating Assets(Q: Mar. 2026 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=697.753 - 5.184
=692.569

Operating Liabilities(Q: Mar. 2026 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=198.544 - 50.555 - 34.094
=113.895

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Scaled Net Operating Assets of 1.84 mean?
Biopol Chemicals (NSE:BIOPOL) has a Scaled Net Operating Assets of 1.84 as of Mar. 2026. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Biopol Chemicals and its competitors.
Is Biopol Chemicals' Scaled Net Operating Assets too high?
Biopol Chemicals' current Scaled Net Operating Assets is 1.84. Overall, Biopol Chemicals has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Biopol Chemicals' Scaled Net Operating Assets compare to LIN and SHW?
Biopol Chemicals' Scaled Net Operating Assets of 1.84 can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Chemicals company?
A good Scaled Net Operating Assets depends on the Chemicals industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Biopol Chemicals and its competitors. Biopol Chemicals's current Scaled Net Operating Assets is 1.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biopol Chemicals stock overvalued right now?
Biopol Chemicals (NSE:BIOPOL) has a current Scaled Net Operating Assets of 1.84. The current Scaled Net Operating Assets is 1.84. Biopol Chemicals' overall GF Score™ is 20/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Biopol Chemicals (NSE:BIOPOL), the current Scaled Net Operating Assets is 1.84 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biopol Chemicals Business Description

Address Street No 372 Action Area 1, Unit No 2ES3B1, 2nd Floor Mani Casadona, IIF Newtown Alia University, North 24 Parganas, Chakpachuria, New town, WB, IND, 700160
Biopol Chemicals Ltd is engaged in the business of trading, manufacturing and distribution of specialty chemicals under the categories of silicones, emulsifiers, biochemicals and polyelectrolytes. Its product portfolio consists of silicone-based products, emulsifier-based products, biochemical products and polyelectrolyte products. It serves various industry segments, including softeners, emulsions and hardeners for textiles; silicone fluids and cleaning chemicals for home care; silicone adjuvants and surfactants in agriculture; and release agents in industrial chemicals. The majority of the company's revenue is derived from the sale of its products to customers in the textile sector.
20GF Score

Get the complete analysis for NSE:BIOPOL

Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹97.80
Price